From Wikipedia, the free encyclopedia
|Systematic (IUPAC) name|
|Mol. mass||191.269 g/mol|
(what is this?) |
3,4-Dimethylmethcathinone (3,4-DMMC) is a stimulant drug first reported in 2010 as a designer drug analogue of mephedrone, apparently produced in response to the banning of mephedrone, following its widespread abuse in many countries in Europe and around the world. 3,4-DMMC has been seized as a designer drug in Australia.
See also[edit source | edit]
References[edit source | edit]
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|